Amrix

Quick links to important sections

Amrix

Method of action: Miorelaxant, Muscle Relaxant

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amrix

This foundational section defines the medicine Amrix (Cyclobenzaprine Hydrochloride), its composition, classification, and general purpose, strictly avoiding dosage, safety, or detailed usage instructions.

Property Description
Active Ingredient Cyclobenzaprine Hydrochloride
Form Extended-release capsule (Oral)
Pharmacological Class Centrally Acting Skeletal Muscle Relaxant (CAMS)
General Purpose Relief from acute muscle spasm
Origin Synthetic Compound (Tricyclic Amine Derivative)

What Type of Medicine is Amrix? (Identity and Classification)

Amrix is a prescription-only medication whose active ingredient is Cyclobenzaprine Hydrochloride, a synthetic compound derived from the tricyclic amine structure. Pharmacologically, it is classified as a skeletal muscle relaxant and, more specifically, a centrally acting skeletal muscle relaxant (CAMS). The role of this therapeutic agent is recognized for its influence on acute, painful musculoskeletal conditions, differentiating its action from traditional pain relievers. The medicine's effect is mediated by the central nervous system to address muscle hyperactivity.

Amrix Composition and Unique Form (Form and Composition)

The preparation is an oral preparation that is supplied as an extended-release capsule, a specific feature that constitutes a key differentiating factor for this product. This formulation is designed to be a single-ingredient product, containing only Cyclobenzaprine Hydrochloride. The extended-release formulation is specifically engineered to release the active substance into the body slowly and steadily over many hours, aiming to maintain prolonged therapeutic levels in the system.

General Purpose of This Muscle Relaxant (High-Level Purpose)

The medication's fundamental purpose is to serve as an adjunct therapy to rest and physical measures for relief of the discomfort associated with acute, involuntary muscle spasm. The action of Amrix is achieved by influencing areas of the brainstem and spinal cord to reduce excessive muscle activity. The drug is typically utilized in scenarios where muscle stiffness and contraction contribute significantly to a patient's pain and restricted motion, helping facilitate a return to more normal muscle movement and function.

Regulatory References

  1. NIH MedlinePlus on Cyclobenzaprine
  2. DailyMed Label: AMRIX

What side effects are possible with Amrix?

Possible Side Effects and Safety Information

The safety profile for Amrix (Cyclobenzaprine Hydrochloride) is defined by categories of adverse reactions and specific limitations, as documented in official government regulatory labeling.

Adverse reactions that are classified as Common (occurring in 1%) primarily involve the Central Nervous System and the Gastrointestinal System. The most frequently documented effects include somnolence (drowsiness), dry mouth, dizziness, fatigue, and headache. Constipation, nausea, and blurred vision are also included in the common findings. Regulatory documents note that these common effects are often reported to occur more frequently at the beginning of treatment and may diminish with continued use.

Serious Adverse Reactions and Safety Constraints

Official labeling identifies several serious, though less frequent, adverse reactions. These include the potential for Serotonin Syndrome, particularly when the medicine is used concurrently with other serotonergic agents. Rare events such as Neuroleptic Malignant Syndrome (NMS)-like symptoms and cases of Hepatic Dysfunction have also been documented in post-marketing reports.

Specific patient safety constraints are detailed:

  • Contraindications: The medicine is contraindicated in individuals with certain pre-existing heart conditions, including Congestive Heart Failure (CHF), Arrhythmias, Conduction Disturbances, or the Acute Recovery Phase of Myocardial Infarction. Use with Monoamine Oxidase Inhibitors (MAOIs), or within 14 days of stopping an MAOI, is also forbidden.
  • Population Notes: Use is not recommended in patients with severe hepatic impairment. Older adults are advised to use caution due to an increased risk of certain CNS-related adverse reactions, such as confusion.

This information establishes a safety structure characterized by transient common effects and specific, mandatory restrictions for high-risk patients.

Overdose and Emergency Response

Overdose and When to Seek Help

Immediate medical attention is required for any suspected overdose of Amrix (cyclobenzaprine). An overdose can be fatal, especially when multiple substances, such as alcohol or other central nervous system (CNS) depressants, are involved. Toxicity is also significantly enhanced by co-ingestion with serotonergic drugs, which can lead to a potentially life-threatening condition called Serotonin Syndrome.

Common Overdose Manifestations Rare but Critical Manifestations
Drowsiness, Tachycardia (fast heartbeat) Cardiac arrest, Severe hypotension (low blood pressure)
Tremor, Agitation, Confusion, Dizziness Cardiac dysrhythmias, Seizures, Neuroleptic Malignant Syndrome (NMS)

Older adults may be at increased risk for adverse effects, including confusion and cardiac events, as the drug is processed more slowly in this population. Serious signs of toxicity may develop rapidly. Therefore, a physician should immediately initiate general supportive measures, including continuous ECG and vital sign monitoring, to protect against severe cardiovascular and CNS events. Treatment involves securing the airway and establishing gastrointestinal decontamination with gastric lavage followed by activated charcoal. Physicians should contact a Poison Control Center for the most current management guidance.

Therapeutic Uses of Amrix

Amrix (cyclobenzaprine extended-release) may be used as a prescription muscle relaxant relevant for easing symptoms related to physical discomfort arising from muscle spasms. The medication is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.

The core benefit contributes to improved comfort during conditions characterized by periods of heightened symptoms and is typically recommended only for short periods. The medication is applied in addressing the muscle spasm and its associated symptoms that interfere with daily functioning. The specific therapeutic aims may assist with easing several signs of distress, which are enumerated as pain, tenderness, and limitation of motion. This is generally used in clinical settings that involve acute or unstable symptom patterns. This focused therapeutic use supports the patient during difficult episodes by easing distress. The primary context remains supportive:

“as an adjunct to rest and physical therapy

Quick Fact: Relief for Muscle Spasm

Regulatory References

  1. NIH DailyMed Official Labeling

Eligibility and Restrictions for Use

Who Can and Cannot Use Amrix?

Eligibility to use Amrix (cyclobenzaprine extended-release) is strictly defined by regulatory documents, focusing on age, concurrent medication use, and pre-existing medical conditions.

Contraindicated and Restricted Populations

Amrix is contraindicated and must not be used by patients who are taking Monoamine Oxidase (MAO) Inhibitors or have used them within 14 days. Absolute contraindications also apply to individuals with hyperthyroidism, as well as those with specific heart conditions, including congestive heart failure, arrhythmias, conduction disturbances, or those in the acute recovery phase following a heart attack.

Age and Organ Function Restrictions

Use is restricted to adults only. Safety and effectiveness have not been established in pediatric patients. Furthermore, use is not recommended for the elderly (65 years of age or older) or for patients with any degree of hepatic impairment (liver dysfunction).

Age Group Eligibility Status
Pediatric Patients Use Not Established
Older Adults (65) Not Recommended

Pregnancy and Specific Conditions

Use during pregnancy is permitted only if clearly needed. Caution must be exercised when administering to a nursing woman, as it is not known if the drug is excreted in human milk. The medication is also not found effective for spasticity associated with cerebral or spinal cord disease.

What should I know about interactions with other medicines?

Amrix (cyclobenzaprine) interacts with several classes of medicines, requiring careful prescribing and patient monitoring.

Contraindicated Combinations

Monoamine Oxidase (MAO) Inhibitors: The use of Amrix is contraindicated concomitantly with, or within 14 days following the discontinuation of, MAO inhibitors (e.g., Linezolid, Phenelzine). This combination can lead to a potentially fatal hyperpyretic crisis, seizures, and severe central nervous system (CNS) toxicity.

Clinically Significant Interactions

Serotonergic Drugs: Concomitant use with other serotonergic agents, including SSRIs, SNRIs, tricyclic antidepressants (TCAs), Bupropion, Tramadol, and Meperidine, increases the risk of developing serotonin syndrome. Symptoms may include mental status changes, hyperthermia, high blood pressure, and neuromuscular issues. If combination therapy is necessary, close observation, especially at treatment initiation or dose increases, is essential.

CNS Depressants: Amrix may enhance the effects of other CNS depressants, including alcohol, barbiturates, benzodiazepines, and opioids. This combination can lead to increased drowsiness, dizziness, and severe respiratory depression.

Anticholinergic Agents: Due to Amrix's own atropine-like action, concurrent use with other anticholinergic medications can result in additive effects, potentially worsening conditions like urinary retention or angle-closure glaucoma.

Mechanism of Action

Cyclobenzaprine acts centrally to influence overactive physiological responses, primarily within the central nervous system (CNS), resulting in modulation of signaling within targeted motor pathways.

Modulating Brain Stem Motor Systems

The compound acts primarily within the brain stem, decreasing efferent signaling associated with heightened somatic motor system output. This central mechanism influences both the gamma (gamma) and alpha (alpha) motor systems, resulting in reduced net efferent discharge to skeletal muscles.


Serotonergic Pathway Adjustment

The drug engages mechanisms that involve serotonin receptor antagonism, particularly at the 5-HT2 receptors, and may also exhibit weak inhibition of norepinephrine and serotonin reuptake. Modifying these early molecular steps in the serotonergic pathway influences descending signal processing, contributing to the mechanism's physiological effect on motor tone.


Central Cholinergic and Histaminic Effects

Cyclobenzaprine is structurally related to tricyclic compounds and exhibits notable central anticholinergic and histamine H1 receptor antagonistic properties. These receptor-mediated signaling effects also influence generalized neuronal activity, resulting in non-specific central nervous system effects.

Dosage and Administration Information

How to Use Amrix

Amrix is an extended-release capsule that is administered via the oral route. The medication is available in two strengths: 15 mg and 30 mg. The dosing regimen is standardized to be taken once daily (QD), ideally at approximately the same time each day to maintain consistent levels of the active substance, Cyclobenzaprine Hydrochloride, in the system. The usual starting dose for adults is 15 mg once daily, with a maximum recommended daily dose of 30 mg.


Administration and Duration

The extended-release capsule must be swallowed whole and intact to ensure the controlled release of the medication over time. For individuals who have difficulty swallowing, an alternative administration method may be used: the entire contents of the capsule may be sprinkled onto one tablespoon of applesauce and swallowed immediately without being chewed. The capsule can be taken with or without food. If a dose is missed, the standard practice is to skip the missed dose and resume the regular schedule; a double dose must not be taken to compensate. Consistent with its intended use, the medication is recommended only for short periods of therapy, typically up to two or three weeks.


Population-Specific Use Restrictions

Specific parameters apply to certain populations. The use of this extended-release formulation is not recommended in elderly patients due to higher plasma concentrations of cyclobenzaprine. Similarly, its use is not recommended for individuals with any degree of hepatic impairment (liver dysfunction). Safety and effectiveness have also not been established for use in patients under 18 years of age.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Amrix

Evidence for Use in Acute Muscle Spasm (Adjunct to Rest and Physical Therapy)

The evidence for Amrix (cyclobenzaprine extended-release) was primarily derived from short-term, randomized controlled trials (RCTs) designed to examine the agent in a regimen with rest and physical measures. Researchers applied the studies in contexts involving fluctuating or unstable symptoms where painful spasms contributed to discomfort and limitations in motion. The trials monitored adult patients experiencing temporary physiological imbalance due to these acute conditions.

The main outcomes used in the research exploring how symptoms change over time included high-level assessments. These included the patient's overall rating of the medication's helpfulness and a physician's assessment of the patient's global response to the assigned treatment regimen. Studies also monitored specific outcomes related to physical discomfort, such as measurements of patient-reported pain intensity, muscle tenderness, and outcomes reflecting daily functioning or activity level.

Duration of Evidence and Follow-up Periods

The studies that monitored Amrix were generally applied in research contexts involving episodic symptom patterns and were designed for short-term evaluation. Research examined temporary physiological imbalance, and the typical observation periods for patient response were very limited, often spanning only one to three weeks.

The existing evidence is limited regarding the use of Amrix for prolonged periods. The regulatory-supported research explored short-term symptom changes but did not monitor long-term outcomes or the durability of symptom response. Consequently, the research describes patterns that apply only to the populations studied during these brief intervals.

Key Research Limitations and Evidence Gaps

Subgroup findings are uncertain, and research does not determine whether an individual will respond similarly to the group patterns observed in the studies. The evidence structure is narrow, focusing only on the approved indication, and does not extend to exploring outcomes in conditions where muscle spasm is chronic or central in origin. The core trials focused on comparisons against a placebo, and comparative evidence with other therapeutic approaches remains insufficient.

Frequently Asked Questions (FAQ)

Common questions about Amrix (FAQ)


Q: Is Amrix considered a benzodiazepine or a tricyclic drug?

Amrix (cyclobenzaprine) is chemically related to the tricyclic antidepressants (TCAs), which is a specific class of compounds. According to official product information, it is classified as a centrally acting skeletal muscle relaxant. It is not considered a benzodiazepine.

Q: Does Amrix (extended-release) work differently than the immediate-release form of cyclobenzaprine?

The fundamental way the drug works to help relax muscles (its mechanism of action) is the same for both the extended-release and immediate-release forms. The difference lies in how the body handles the medicine. The extended-release formulation is specifically engineered to release the drug into the system slowly and steadily over many hours.

Q: Why is Amrix sometimes prescribed over the immediate-release version?

The extended-release design is primarily intended for patient convenience and consistency of medication levels. Official prescribing information indicates that this formulation allows the medication to be taken just once daily, compared to multiple times a day for the immediate-release tablets.

Q: How long does the effect of one Amrix capsule typically last?

Amrix is an extended-release capsule designed for once-daily dosing. The medication is engineered to release the active substance over a prolonged period. This slow and steady release aims to maintain consistent levels of the drug in the body throughout the day.

Q: Are there mental or mood side effects associated with Amrix, such as confusion?

Mental status changes are potential adverse reactions that have been reported with cyclobenzaprine. These changes may include confusion, agitation, or hallucinations, and are also noted as potential symptoms of a serious condition called Serotonin Syndrome. Furthermore, official documents specifically note that confusion is a risk for older adults taking this medication.

Q: Can people with glaucoma use Amrix?

Amrix has an effect similar to atropine, which is noted in its prescribing information. Because of this action, caution is generally advised for people who have a history of angle-closure glaucoma or increased pressure in the eye.

Q: Is Amrix safe for use during pregnancy?

Official product information classifies Amrix as Pregnancy Category B. This means that while animal studies have not demonstrated a risk to the fetus, there are no adequate and well-controlled studies specifically conducted in pregnant women. Official prescribing information states the drug should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Q: Is it possible for Amrix to affect a nursing infant?

It is not currently known whether cyclobenzaprine is passed into human milk. Regulatory guidance advises that caution should be exercised when considering administration of the medication to a nursing woman.

Q: What types of other pain medications might interact with Amrix?

Amrix can enhance the effects of Central Nervous System (CNS) depressants, including opioid pain medicines. Official documents state this combination may lead to increased drowsiness and dizziness. Furthermore, using Amrix with other serotonergic pain medications, such as Tramadol, is described as increasing the risk of a serious condition called Serotonin Syndrome.

Q: Is Amrix a type of opioid or narcotic?

No, Amrix (cyclobenzaprine) is a skeletal muscle relaxant. It is not classified as an opioid, narcotic, or controlled substance according to DEA classifications.

Q: Is anxiety or nervousness a reported side effect of Amrix?

Regulatory documents indicate that nervousness has been reported as an adverse reaction in clinical experience with cyclobenzaprine. This finding is included in the official safety documents alongside other documented side effects.

Q: Is there a risk of developing a physical dependence on Amrix?

The potential for drug dependence and abuse has not been fully evaluated for cyclobenzaprine. However, according to official product information, dependence is generally not associated with this medication.

Q: What are the typical signs of stopping Amrix after a period of use?

The abrupt discontinuation of cyclobenzaprine after a period of consistent use may result in certain physical symptoms. These symptoms, described in the official label, may include nausea, headache, and a general sense of feeling unwell (malaise).

Q: Does Amrix interact with common over-the-counter cold and flu medicines?

Many common cold and flu medicines contain ingredients that can cause drowsiness (CNS depressants) or have anticholinergic properties. Because Amrix has similar effects, taking it with these types of over-the-counter products can result in additive effects, potentially increasing the risk of side effects like increased drowsiness or dry mouth.

Q: Does Amrix interact with herbal supplements like St. John's Wort?

Official safety information indicates caution is needed regarding supplements. Because St. John's Wort is considered a serotonergic agent (affecting serotonin levels), using Amrix with this supplement can increase the potential risk of developing Serotonin Syndrome, a potentially serious condition.

Q: How quickly does Amrix typically start to work after the first dose?

The extended-release design means the drug level in the blood builds up over several hours. Pharmacokinetic studies of the drug's release profile indicate that the maximum concentration in the body, known as T max, was observed to be approximately seven to eight hours in those studies.

Q: How does the body eliminate Amrix?

Cyclobenzaprine is extensively processed (metabolized) by the liver using specific enzymes, primarily via the CYP450 system. After metabolism, the drug's byproducts (inactive metabolites) are then primarily removed from the body through the kidneys.

How should Amrix be stored and disposed of?

How to Store and Dispose of Amrix (Cyclobenzaprine Extended-Release Capsules)

Amrix must be stored at 25 C (77 F), corresponding to Controlled Room Temperature. The permitted temperature range, as specified in regulatory labeling, allows excursions between 15 C and 30 C (59 F and 86 F). The medication must be protected from both light and moisture and should be kept from freezing.

Storage Requirement Condition
Temperature 25 C (77 F)
Protection Keep from freezing; protect from light and moisture.
Container Store in a tight, light-resistant container.

Keep Amrix out of the reach of children and pets. If the capsule contents are sprinkled onto food, any unused portion of the medicine must be discarded immediately. Unused or expired medication should be disposed of via a drug take-back program or according to official guidance for safe household trash disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amrix found in:

A-Z Index: